Novartis AG (LTS:0K9E) Transcripts
Q3 2024 Novartis AG Earnings Call Transcript
Oct 29, 2024
$110.45
(-4.41%)
Earnings
Q2 2024 Novartis AG Earnings Call Transcript
Jul 18, 2024
$107
(-4.55%)
Earnings
Q1 2024 Novartis AG Earnings Call Transcript
Apr 23, 2024
$97.31
(+1.40%)
Earnings
Novartis AG Annual Shareholders Meeting Transcript
Mar 05, 2024
MorphoSys AG to be Acquired by Novartis AG Call Transcript
Feb 06, 2024
Q4 2023 Novartis AG Earnings Call Transcript
Jan 31, 2024
$103.8
(-3.45%)
Earnings
Novartis AG at JPMorgan Healthcare Conference Transcript
Jan 08, 2024
Novartis AG R&D Day Transcript
Nov 28, 2023
Novartis AG Impact & Sustainability Annual Event Transcript
Nov 13, 2023
Q3 2023 Novartis AG Earnings Call Transcript
Oct 24, 2023
$95.17
(+0.30%)
Earnings
Novartis AG PSMAfore Data at ESMO Presentation Transcript
Oct 24, 2023
Q2 2023 Novartis AG Earnings Call Transcript
Jul 18, 2023
$96.62
(+4.54%)
Earnings
Novartis AG - Sandoz Capital Markets Day (UK) Transcript
Jun 12, 2023
Novartis AG - Sandoz Capital Markets Day (USA) Transcript
Jun 08, 2023
Novartis AG at ASCO Investor Meeting (Virtual) Transcript
Jun 05, 2023
Q1 2023 Novartis AG Earnings Call Transcript
Apr 25, 2023
$97.16
(+3.08%)
Earnings
Novartis AG Annual Shareholders Meeting Transcript
Mar 07, 2023
Q4 2022 Novartis AG Earnings Call Transcript
Feb 01, 2023
$81.86
(-2.92%)
Earnings
Novartis AG at JPMorgan Healthcare Conference Transcript
Jan 09, 2023
Novartis AG to Discuss Iptacopan ASH Update Transcript
Dec 13, 2022
Novartis AG Investor Update on Access & Sustainability Transcript
Nov 30, 2022
Q3 2022 Novartis AG Earnings Presentation Transcript
Oct 25, 2022
Meet Novartis AG Management Investor Event Transcript
Sep 22, 2022
Novartis AG Announces Intention to Separate Sandoz Business to Create a Standalone Company Call Transcript
Aug 25, 2022
Novartis AG Announces Intention to Separate Sandoz Business to Create a Standalone Company Call - Media Transcript
Aug 25, 2022
Q2 2022 Novartis AG Earnings Call Transcript
Jul 19, 2022
$80.58
(+2.77%)
Earnings
Q1 2022 Novartis AG Earnings Call Transcript
Apr 26, 2022
$84.44
(+0.89%)
Earnings
Novartis AG New Organizational Model Investor Call Transcript
Apr 04, 2022
Novartis AG Annual Shareholders Meeting Transcript
Mar 04, 2022
Q4 2021 Novartis AG Earnings Call Transcript
Feb 02, 2022
$80.54
(-2.49%)
Earnings
Novartis AG at JPMorgan Healthcare Conference (Virtual) Transcript
Jan 10, 2022
Novartis AG Leqvio® FDA Approval Investor Call Transcript
Dec 23, 2021
Novartis AG R&D Day (Virtual) Transcript
Dec 02, 2021
Novartis AG at Novartis Co-Creating Impact Summit (Virtual) - Morning Session Transcript
Dec 02, 2021
Novartis AG Webinar: Integrating ESG Into Strategy Transcript
Nov 12, 2021
Q3 2021 Novartis AG Earnings Call Transcript
Oct 26, 2021
$79.22
(+0.85%)
Earnings
Novartis AG ESG Investor Day Transcript
Sep 30, 2021
Q2 2021 Novartis AG Earnings Call Transcript
Jul 21, 2021
$84.49
(-0.10%)
Earnings
Novartis AG Iptacopan (LNP023) Update Call Transcript
Jun 22, 2021
Novartis AG Oncology Update Call Transcript
Jun 08, 2021
Novartis AG Cardiovascular Update Call Transcript
May 18, 2021
Q1 2021 Novartis AG Earnings Call Transcript
Apr 27, 2021
$81.1
(-1.50%)
Earnings
Novartis AG Annual Shareholders Meeting Transcript
Mar 02, 2021
Novartis AG at SVB Leerink Global Healthcare Conference (Virtual) Transcript
Feb 25, 2021
Novartis AG to Discuss Entresto® FDA Label Expansion Investor Q&A Call Transcript
Feb 17, 2021
Novartis AG Materiality Assessment Webinar: Dialogue Matters Transcript
Feb 08, 2021
Q4 2020 Novartis AG Earnings Call Transcript
Jan 26, 2021
$89.25
(-1.97%)
Earnings
Novartis AG at JPMorgan Healthcare Conference (Virtual) Transcript
Jan 11, 2021
Novartis AG, ABN Amro Bank NV & BlackRock Inc at Novartis Co-Creating Impact Summit (Virtual) - PM Session Transcript
Dec 09, 2020
Novartis AG at Novartis Co-Creating Impact Summit (Virtual) - AM Session Transcript
Dec 09, 2020
Virtual Meet Novartis AG Management Investor Event Transcript
Nov 24, 2020
Q3 2020 Novartis AG Earnings Call Transcript
Oct 27, 2020
$78.56
Earnings
Novartis AG ESG Investor Event Transcript
Sep 01, 2020
Novartis AG to Discuss Kesimpta® FDA Approval Investor Call Transcript
Aug 21, 2020
Q2 2020 Novartis AG Earnings Call Transcript
Jul 21, 2020
$82.56
Earnings
Novartis AG to Discuss the Oncology Pipeline Update Call Transcript
Jun 15, 2020
Novartis AG at UBS Global Healthcare Conference (Virtual) Transcript
May 20, 2020
Q1 2020 Novartis AG Earnings Call Transcript
Apr 28, 2020
$84.34
Earnings
Novartis AG to Discuss Zolgensma® MDA Data Call Transcript
Mar 30, 2020
Novartis AG Annual Shareholders Meeting Transcript
Feb 28, 2020
Q4 2019 Novartis AG Earnings Call Transcript
Jan 29, 2020
Earnings
Salesforce.Com Inc, UnitedHealth Group Inc, Alphabet Inc, Color, and Novartis AG at JPMorgan Healthcare Conference Panel Transcript
Jan 15, 2020
Novartis AG at JPMorgan Healthcare Conference Transcript
Jan 13, 2020
Novartis AG R&D Day Transcript
Dec 05, 2019
Novartis AG to Acquire The Medicines Company for USD 9.7 Billion Call Transcript
Nov 25, 2019
Q3 2019 Novartis AG Earnings Call Transcript
Oct 22, 2019
Earnings
Novartis AG to Discuss Beovu® FDA Approval Investor Call Transcript
Oct 08, 2019
Novartis AG to Discuss Kisqali® MONALEESA-3 ESMO Data Investor Call Transcript
Oct 01, 2019
Novartis AG to Discuss Ofatumumab (OMB157) ECTRIMS Data Investor Call Transcript
Sep 16, 2019
Novartis AG ESG Investor Event Transcript
Sep 09, 2019
Novartis AG to Discuss the Zolgensma® Update Call Transcript
Aug 07, 2019
Q2 2019 Novartis AG Earnings Call Transcript
Jul 18, 2019
Earnings
Novartis AG to Discuss the Zolgensma® and Piqray® US FDA Approvals Call Transcript
May 27, 2019
Meet Novartis AG Management Investor Event - Breakout Sessions (Day 2) Transcript
May 23, 2019
Meet Novartis AG Management Investor Event - CEO Introduction (Day 2) Transcript
May 23, 2019
Novartis AG to Discuss Acquisition of Xiidra® from Takeda Pharmaceutical Co Ltd Call Transcript
May 09, 2019
Novartis AG to Discuss Zolgensma (AVXS-101) Clinical Data Call Transcript
May 08, 2019
Q1 2019 Novartis AG Earnings Call Transcript
Apr 24, 2019
Earnings
Novartis AG at Alliance for Regenerative Medicine Cell & Gene Meeting on the Mediterranean Transcript
Apr 23, 2019
Novartis AG Mayzent FDA Approval Investor Call Transcript
Mar 27, 2019
Novartis AG Annual Shareholders Meeting Transcript
Feb 28, 2019